Skip to main content

Xometry Obtains Certification for Medical Device Manufacturing

Written by Customer Service on . Posted in Public Companies.

  • With ISO 13485 certification, the Xometry marketplace broadens medical device production 
  • Xometry currently works with 86 percent of Fortune 500 medical product and equipment companies

ROCKVILLE, Md., March 31, 2022 (GLOBE NEWSWIRE) — Xometry, the digital marketplace for manufacturing, today announced it has obtained ISO 13485 certification, enabling the company to expand the breadth of medical device manufacturing on the Xometry marketplace.

The certification significantly broadens Xometry’s already large footprint in the medical industry. Xometry currently works with 86 percent of Fortune 500 medical product and equipment companies, providing prototyping and manufacturing support.

The Xometry marketplace helps companies across all industries develop and deliver next-generation products that are fueling tomorrow’s economy.

For more information about Xometry’s ISO 13485 and other certifications, please visit the company’s certifications page.

About Xometry
Xometry (NASDAQ:XMTR) powers the industries of today and tomorrow by connecting the people with the big ideas to the manufacturers who can bring them to life. Xometry’s digital marketplace makes it easy for buyers at Fortune 1000 companies to access global manufacturing capacity, while giving suppliers the critical resources they need to grow their business. Xometry is home to Thomas, a leader in product sourcing, supplier selection and marketing solutions for industry, and the popular Thomasnet.com platform.

Media contact:
Matthew.Hutchison@Xometry.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.